Immuneering (IMRX) Intangibles (2021 - 2026)
Immuneering (IMRX) reported Intangibles of $306,513 for Q2 2026, down 8.7% from $335,780 a year earlier and down 2.3% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Intangibles (2021 - 2026) Analysis & Trends
At the end of FY2025, Immuneering posted Intangibles of $321,147, down 8.4% from FY2024.
- Intangibles has declined for four consecutive years, with a four-year compound annual growth rate of -7.5% (FY2021 to FY2025).
- By year, Intangibles came in at $350,413 in FY2024 (-7.7%), $379,680 in FY2023 (-7.2%), $408,947 in FY2022 (-6.8%) and $439,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Intangibles in data going back to Q4 2021.
- Year over year, Intangibles has now declined in each of the last 15 quarters, with an average decline of 8.1% over the last eight quarters.
- Over the past five years, the year-over-year decline in Intangibles ranged from 6.8% (Q1 2023) to 8.7% (Q2 2026).
- Per Business Quant data, the three quarters before Q2 2026 came in at $313,830 (Q1 2026), $321,147 (Q4 2025) and $328,463 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Immuneering | 267.20 Mn | 267.20 Mn | - | 306,513.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 306,513.00 |
| Mar 31, 2026 | 313,830.00 |
| Dec 31, 2025 | 321,147.00 |
| Sep 30, 2025 | 328,463.00 |
| Jun 30, 2025 | 335,780.00 |
| Mar 31, 2025 | 343,097.00 |
| Dec 31, 2024 | 350,413.00 |
| Sep 30, 2024 | 357,730.00 |
| Jun 30, 2024 | 365,047.00 |
| Mar 31, 2024 | 372,363.00 |
| Dec 31, 2023 | 379,680.00 |
| Sep 30, 2023 | 386,997.00 |
| Jun 30, 2023 | 394,313.00 |
| Mar 31, 2023 | 401,630.00 |
| Dec 31, 2022 | 408,947.00 |
| Sep 30, 2022 | 416,263.00 |
| Jun 30, 2022 | 423,580.00 |
| Mar 31, 2022 | 430,897.00 |
| Dec 31, 2021 | 439,000.00 |
API Access
Immuneering Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();